Optimal Antiplatelet Therapy During Percutaneous Coronary Interventions Includes Glycoprotein IIb/IIIa Inhibitors. Just Eliminate the Infusion

Ehtisham Mahmud, Anand Prasad

Research output: Contribution to journalEditorialpeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)846-848
Number of pages3
JournalJournal of the American College of Cardiology
Volume53
Issue number10
DOIs
StatePublished - Mar 10 2009

Keywords

  • eptifibatide
  • glycoprotein IIb/IIIa blockade
  • ischemic complications after PCI
  • percutaneous coronary intervention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this